Novo’s obesity drug has serious warnings and barriers to overcome
World of DTC Marketing
JUNE 6, 2021
The headlines read “FDA approves obesity drug that helped people cut weight 15%” But buyer beware. The drug already exists at a lower dose as an anti-diabetic medication under the brand names Ozempic and Rybelsus made by the same pharmaceutical company, Novo Nordisk.
Let's personalize your content